Literature DB >> 16380990

Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE).

Ali M Qaisi1, Maha F Tutunji, Lara F Tutunji.   

Abstract

The reactions of omeprazole, a potent proton pump inhibitor (PPI), were investigated in the absence of a nucleophile. Reactions were monitored, using differential pulse polarography (DPP) at the static mercury drop electrode (SMDE), in solutions buffered to pH values ranging from 2.0 to 8.0. The fast, sensitive, and selective electrochemical technique facilitated to repeat recordings of successive voltammograms [peak current (nA) vs. peak potential (volts vs. Ag/AgCl saturated with 3.0 M KCl)]. The DPP signals of omeprazole and its degradation products, believed to be due to sulfur functional group (the principal site of electrode reaction), gave advantages over the previously employed UV detection technique. The latter primarily relied on pyridine and benzimidazole analytical signals, which are common reaction products of PPI in aqueous acidic solutions. After peak identification, the resulting current (nA)-time (s) profiles, demonstrated that omeprazole undergoes degradation to form two main stable compounds, the first is the cyclic sulfenamide (D(+)), previously believed to be the active inhibitor of the H(+), K(+)-ATPase, the second is omeprazole dimer. This degradation is highly dependant on pH. Unlike previous studies which reported that the lifetime of D(+) is few seconds, the cyclic sulfenamide (D(+)) was found to be stable for up to 5-20 min. The results further indicated that omeprazole converts into the cyclic sulfenamide in an irreversible reaction, consequently, D(+) and sulfenic acid (an intermediate which rapidly converts into D(+)) were not interconvertable. The present work suggested that the sulfenic acid is the active inhibitor in vivo. In addition, the omeprazole reactions, in the absence of the thiol, were not as complicated as were previously reported. Copright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16380990     DOI: 10.1002/jps.20546

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms.

Authors:  Ashraf M Mahmoud
Journal:  Int J Anal Chem       Date:  2009-12-02       Impact factor: 1.885

2.  A Validated High-Throughput Fluorometric Method for Determination of Omeprazole in Quality Control Laboratory via Charge Transfer Sensitized Fluorescence.

Authors:  Ashraf M Mahmoud; Sameh A Ahmed
Journal:  J Fluoresc       Date:  2015-12-03       Impact factor: 2.217

3.  Voltammetric Behavior and Determination of Trace Amounts of Omeprazole Using an Edge-plane Pyrolytic Graphite Electrode.

Authors:  Saeed Shahrokhian; Masoumeh Ghalkhani; Maryam Bayat; Fatemeh Ghorbani-Bidkorbeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Synthesis, characterization, anti-ulcer action and molecular docking evaluation of novel benzimidazole-pyrazole hybrids.

Authors:  Abida Noor; Neelum Gul Qazi; Humaira Nadeem; Arif-Ullah Khan; Rehan Zafar Paracha; Fawad Ali; Adil Saeed
Journal:  Chem Cent J       Date:  2017-09-02       Impact factor: 4.215

5.  Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Tep Keila; Tey Sovannarith; Heng Bun Kiet; Eav Dararth; Theingi Zin; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-03       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.